See more news releases in Health Care & Hospitals | Medical Equipment | Medical Pharmaceuticals

Hologic to Present at Two Upcoming Investor Conferences

BEDFORD, Mass., Aug. 7, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that Jack W. Cumming, President and Chief Executive Officer, will present at the following conferences:

Canaccord Genuity 33^rd Annual Growth Conference in Boston, Massachusetts on Wednesday, August 14, 2013 at 8 a.m. Eastern Time.
Morgan Stanley Global Healthcare Conference in New York City, New York on Tuesday, September 10, 2013 at 12:55 p.m. Eastern Time.

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

Contacts:

Deborah R. Gordon	Al Kildani
Vice President, Investor Relations	Senior Director, Investor Relations
(781) 999-7716	(858) 410-8653
deborah.gordon@hologic.com	al.kildani@hologic.com